Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Working Capital Changes (2016 - 2025)

China Pharma Holdings' Other Working Capital Changes history spans 16 years, with the latest figure at -$46849.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 54.69% year-over-year to -$46849.0; the TTM value through Dec 2025 reached -$53444.0, down 93.88%, while the annual FY2025 figure was -$53444.0, 93.88% down from the prior year.
  • Other Working Capital Changes reached -$46849.0 in Q4 2025 per CPHI's latest filing, down from $178.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $656671.0 in Q3 2023 to a low of -$483110.0 in Q2 2023.
  • Average Other Working Capital Changes over 5 years is -$2635.2, with a median of -$6600.5 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: soared 1007.48% in 2022, then plummeted 1967.67% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$15106.0 in 2021, then skyrocketed by 1007.48% to $137084.0 in 2022, then plummeted by 225.9% to -$172583.0 in 2023, then soared by 82.45% to -$30285.0 in 2024, then crashed by 54.69% to -$46849.0 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Other Working Capital Changes are -$46849.0 (Q4 2025), $178.0 (Q3 2025), and $41246.0 (Q2 2025).